Evaluation of Prognosis and Risk of Death by Neutrophil/Lymphocyte Ratio, C-Reactive Protein/Albumin Ratio and Plasma D-Dimer in Patients with Pulmonary Thromboembolism

• Published in: International journal of general medicine Vol. 14; pp. 9219 - 9225
• Main Authors: Shan, Tiantian, Li, Xinran, Yan, Min, Pan, Xiangtao
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 01.01.2021; Taylor & Francis Ltd; Dove; Dove Medical Press
• Subjects: c-reactive protein/albumin ratio; Comparative analysis; Correlation analysis; Disease; Embolisms; Gender; Hematology; Hemoglobin; Hospitals; Inflammation; Lymphocytes; Medical imaging; Medical prognosis; Medical records; Medical research; Medicine, Experimental; neutrophil to lymphocyte ratio; Neutrophils; Original Research; plasma d-dimer; Prognosis; Proteins; pulmonary thromboembolism; Regression analysis; Risk assessment; risk assessment of death; Statistical analysis; Thromboembolism; C-reactive protein/albumin ratio; neutrophil to lymphocyte ratio; pulmonary thromboembolism; prognosis; plasma D-dimer; risk assessment of death
• ISSN: 1178-7074; 1178-7074
• DOI: 10.2147/IJGM.S343039

To investigate the relationship between neutrophil/lymphocyte ratio, C-reactive protein/albumin ratio, plasma D-dimer and prognosis in patients with pulmonary thromboembolism, and to evaluate the risk of death. We retrospectively analyzed peripheral hematology and coagulation-related indicators of 362 pulmonary thromboembolism patients and 32 normal people, and the differences between the patients and control group and between good and poor prognosis groups were compared. And we analyzed and compared separate detection and combined detection of neutrophil/lymphocyte ratio, C-reactive protein/albumin ratio and D-dimer on the efficiency of risk of death in patients. ① Neutrophil/lymphocyte ratio of pulmonary thromboembolism patients was 8.96±1.94, significantly higher than that of control group 1.76±0.53 ( =2.4281, <0.05). C-reactive protein/albumin ratio was 2.13±2.08, significantly higher than 0.03±0.01 in control group ( =20.7736, <0.01). D-dimer was 9.69±8.61mg/L, significantly higher than 0.20±0.11mg/L in control group ( =3.0066, <0.01). ② Hemoglobin, lymphocyte, albumin and lymphocyte/monocyte ratio in patients with good prognosis were significantly lower than those in poor prognosis group, while white blood cell, C-creative protein, neutrophil, C-reactive protein/albumin ratio, neutrophil/lymphocyte ratio and D-dimer were significantly lower than those in poor prognosis group ( all <0.05). ③ Regression analysis showed that neutrophil/lymphocyte ratio ( =0.007), C-reactive protein/albumin ratio ( =0.010) and D-dimer ( =0.003) were independent prognostic factors for pulmonary thromboembolism. ④ In assessing the risk of death of patients, D-dimer alone had the highest sensitivity (93.1%), and C-reactive protein/albumin ratio alone had the highest specificity (68.8%). The combined detection of these three indicators had higher sensitivity (86.2%) and higher specificity (67.6%) at the same time. ⑤ The area under receiver operating characteristic curve for combined detection of neutrophil/lymphocyte ratio, C-reactive protein/albumin ratio and D-dimer was the largest (up to 0.821). Patients with pulmonary thromboembolism highly expressed in neutrophil/lymphocyte ratio, C-reactive protein/albumin ratio and D-dimer. The combined detection of these three indicators can improve the assessment efficacy of the risk of death in patients with pulmonary thromboembolism.